story of the week
Nivolumab and Ipilimumab for Patients With Advanced Rare Genitourinary Malignancies
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Results of a Multicenter, Phase 2 Study of Nivolumab and Ipilimumab for Patients With Advanced Rare Genitourinary Malignancies
Cancer 2020 Nov 20;[EPub Ahead of Print], BA McGregor, MT Campbell, W Xie, S Farah, MA Bilen, AL Schmidt, GP Sonpavde, KL Kilbridge, AD Choudhury, A Mortazavi, AY Shah, AM Venkatesan, GJ Bubley, AO Siefker-Radtke, RR McKay, TK ChoueiriFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.